Literature DB >> 8977606

T lymphocytes and silica-induced pulmonary inflammation and fibrosis in mice.

N Suzuki1, K Ohta, T Horiuchi, H Takizawa, T Ueda, M Kuwabara, J Shiga, K Ito.   

Abstract

BACKGROUND: Silica-induced pulmonary inflammation and fibrosis in animals provides a good model for chronic pulmonary inflammation and fibrosis. Although lymphocytes are implicated in the pathogenesis of pulmonary fibrosis, experimental models using silica-treated athymic nude mice have not been successful in showing the fibrogenic mechanism regulated by T cells. The aim of this study was to re-evaluate the role of T lymphocytes in the development of silicosis by comparing the response to silica administration of nude athymic mutants with that of euthymic animals.
METHODS: Suspensions of silica particles were transnasally administered to nude athymic mice (Balb/c nu/nu) as well as to their euthymic littermates (Balb/c nu/+). The degree of pulmonary inflammation and fibrosis was assessed on days 14, 28, and 56 based upon histological observation, analysis of collagen deposition in the lungs, and analysis of the cellular constituent, protein, and phospholipid content in the bronchoalveolar lavage fluid.
RESULTS: Histologically, athymic mice developed less severe interstitial pneumonitis than euthymic mice. In euthymic mice the lung hydroxyproline content increased with time after silica administration from 6.48 (0.38) micrograms hydroxyproline/mg dry lung weight on day 0 to 8.87 (0.41) micrograms/mg on day 56. A gradual increase in lung hydroxyproline content was also observed in athymic mice but the increase was significantly smaller than in euthymic mice (6.63 (0.43) micrograms/mg on day 0, 7.90 (0.19) micrograms/mg on day 56). Administration of silica resulted in an increase in the number of macrophages and neutrophils and in the total protein and phospholipid content of the bronchoalveolar lavage (BAL) fluid in both mouse strains. No significant difference was detected between athymic and euthymic mice in the numbers of macrophages, but the increase in neutrophils in the BAL fluid of athymic mice was significantly smaller than in euthymic mice on days 14 and 56. The total protein and phospholipid content of the BAL fluid from athymic mice was lower than that from euthymic mice.
CONCLUSIONS: T lymphocytes appear to be involved in the pathogenesis of silica-induced pneumonitis. Since pulmonary fibrosis develops even in nude athymic mice, T cells do not seem to play a primary part in fibrogenic response but they regulate, at least to some extent, the response of inflammatory cells and fibrogenesis of the lung.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977606      PMCID: PMC472659          DOI: 10.1136/thx.51.10.1036

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  40 in total

1.  Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

Authors:  S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

Review 2.  Interleukins and the immune system 2.

Authors:  A O'Garra
Journal:  Lancet       Date:  1989-05-06       Impact factor: 79.321

Review 3.  Pathogenesis of silicosis: current concepts and hypotheses.

Authors:  G S Davis
Journal:  Lung       Date:  1986       Impact factor: 2.584

4.  Idiopathic pulmonary fibrosis: cellular and molecular pathogenesis.

Authors:  J C Weissler
Journal:  Am J Med Sci       Date:  1989-02       Impact factor: 2.378

5.  Experimental alveolar lipo-proteinosis following the inhalation of silica.

Authors:  A G Heppleston; N A Wright; J A Stewart
Journal:  J Pathol       Date:  1970-08       Impact factor: 7.996

6.  Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.

Authors:  H Y Reynolds; J D Fulmer; J A Kazmierowski; W C Roberts; M M Frank; R G Crystal
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

7.  Role of polymorphonuclear leukocytes in silica-induced pulmonary fibrosis.

Authors:  I Y Adamson; D H Bowden
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

8.  Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis.

Authors:  P F Piguet; M A Collart; G E Grau; A P Sappino; P Vassalli
Journal:  Nature       Date:  1990-03-15       Impact factor: 49.962

9.  Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis.

Authors:  J A Schmidt; C N Oliver; J L Lepe-Zuniga; I Green; I Gery
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

10.  Pathogenesis of pulmonary fibrosis in interstitial lung disease. Alveolar macrophage PDGF(B) gene activation and up-regulation by interferon gamma.

Authors:  R J Shaw; S H Benedict; R A Clark; T E King
Journal:  Am Rev Respir Dis       Date:  1991-01
View more
  11 in total

1.  Longitudinal study of a mouse model of chronic pulmonary inflammation using breath hold gated micro-CT.

Authors:  Xabier Artaechevarria; David Blanco; Daniel Pérez-Martín; Gabriel de Biurrun; Luis M Montuenga; Juan P de Torres; Javier J Zulueta; Gorka Bastarrika; Arrate Muñoz-Barrutia; Carlos Ortiz-de-Solorzano
Journal:  Eur Radiol       Date:  2010-06-24       Impact factor: 5.315

2.  Innate immune processes are sufficient for driving silicosis in mice.

Authors:  Celine A Beamer; Christopher T Migliaccio; Forrest Jessop; Melanie Trapkus; Dorothy Yuan; Andrij Holian
Journal:  J Leukoc Biol       Date:  2010-06-24       Impact factor: 4.962

3.  CD4+CD25+Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice.

Authors:  Fangwei Liu; Jie Liu; Dong Weng; Ying Chen; Laiyu Song; Qincheng He; Jie Chen
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

4.  Complex regulation of pulmonary inflammation and fibrosis by CCL18.

Authors:  Kerill Pochetuhen; Irina G Luzina; Virginia Lockatell; Jung Choi; Nevins W Todd; Sergei P Atamas
Journal:  Am J Pathol       Date:  2007-06-14       Impact factor: 4.307

5.  Suppressive oligodeoxynucleotides inhibit silica-induced pulmonary inflammation.

Authors:  Takashi Sato; Takeshi Shimosato; W Gregory Alvord; Dennis M Klinman
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

6.  Tregs promote the differentiation of Th17 cells in silica-induced lung fibrosis in mice.

Authors:  Laiyu Song; Dong Weng; Fangwei Liu; Ying Chen; Cuiying Li; Lei Dong; Wen Tang; Jie Chen
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

7.  Fas ligand triggers pulmonary silicosis.

Authors:  V M Borges; H Falcão; J H Leite-Júnior; L Alvim; G P Teixeira; M Russo; A F Nóbrega; M F Lopes; P M Rocco; W F Davidson; R Linden; H Yagita; W A Zin; G A DosReis
Journal:  J Exp Med       Date:  2001-07-16       Impact factor: 14.307

8.  Co-localization of iron binding on silica with p62/sequestosome1 (SQSTM1) in lung granulomas of mice with acute silicosis.

Authors:  Yasuo Shimizu; Kunio Dobashi; Hiroyuki Nagase; Ken Ohta; Takaaki Sano; Shinichi Matsuzaki; Yoshiki Ishii; Takahiro Satoh; Masashi Koka; Akihito Yokoyama; Takeru Ohkubo; Yasuyuki Ishii; Tomihiro Kamiya
Journal:  J Clin Biochem Nutr       Date:  2014-11-28       Impact factor: 3.114

9.  Blockade of Wnt/β-Catenin Pathway Aggravated Silica-Induced Lung Inflammation through Tregs Regulation on Th Immune Responses.

Authors:  Wujing Dai; Fangwei Liu; Chao Li; Yiping Lu; Xiaowei Lu; Sitong Du; Ying Chen; Dong Weng; Jie Chen
Journal:  Mediators Inflamm       Date:  2016-03-16       Impact factor: 4.711

10.  Combined effect of silica dust exposure and cigarette smoking on total and cause-specific mortality in iron miners: a cohort study.

Authors:  Hanpeng Lai; Yuewei Liu; Min Zhou; Tingming Shi; Yun Zhou; Shaofan Weng; Weihong Chen
Journal:  Environ Health       Date:  2018-05-09       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.